TCM Biotech International Corp.
4169
Rank in Stocks
#15688
TCM Biotech International Corp., a biotech company, engages in the research and... TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Share Price
$3.69
Last synced: 2026-11-13
Market Cap
$245.02M
Change (1 day)
0.21%
Change (1 year)
-40.37%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade TCM Biotech International Corp. (4169)
Category
Healthcare
Operating Margin for TCM Biotech International Corp. (4169)
Operating Margin as of November 2026 TTM: -3.72%
According to TCM Biotech International Corp.'s latest financial reports, its current operating margin (TTM) is -3.72%. At the end of 2025 the company had an operating margin of 2.72%.
Operating Margin history for TCM Biotech International Corp. from 2025 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -3.72% | -236.76% |
| 2025 | 2.72% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| -195.39% | -47.48% |
US
|
|
| 33.87% | -109.10% |
US
|
|
| -116.04% | -68.81% |
US
|
|
| 25.57% | -106.87% |
AU
|
|
| 31.23% | -108.40% |
BE
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about TCM Biotech International Corp.'s operating margin
What is TCM Biotech International Corp.'s operating margin?
TCM Biotech International Corp.'s operating margin is -3.72%, as of Nov 2026.
How does TCM Biotech International Corp.'s operating margin compare with similar companies?
TCM Biotech International Corp.'s operating margin (-3.72%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.